Novan Inc Financials

Novan Stock Summary

Novan competes with Tarsus Pharmaceuticals, Aldeyra, Travere Therapeutics, Eton Pharmaceuticals, and Tonix Pharmaceuticals. Novan, Inc., a medical dermatology company, focuses on researching, developing, and commercializing therapeutic products for skin diseases. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina. Novan operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.

Novan Key Financial Ratios

Novan Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Novan's current stock value. Our valuation model uses many indicators to compare Novan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novan competition to find correlations between indicators driving Novan's intrinsic value. More Info.Novan Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novan's earnings, one of the primary drivers of an investment's value.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

If you are still planning to invest in Novan Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novan's history and understand the potential risks before investing.